Support for submission to MSAC for MRD testing reimbursement in ALL
- Acute lymphoblastic leukaemia
- Treatments and side-effects
Andrew was the first person in Western Australia to have the life-changing therapy.
Ann Bruce shares the story of her diagnosis, in her own words.
Zoe Li was a healthy baby when she was born, but five weeks later her parents were told the shocking news… she had leukaemia. Â
Ciltacabtagene autoleucel (cilta-cel), is being appraised by the Medical Services Advisory Committee (MSAC) for listing on the Medicare Benefits Schedule.Â
It’s emerging in all cancers, but particularly in the MPNs, that “genomics is everything” according to Professor Andrew Perkins, an expert in myeloproliferative neoplasms (MPN).
Diagnosed with PV and ET at the age of 18, Sharon was having treatment when she fell pregnant with the first of her three healthy children in 2000.
Noemi Horvath is a highly reputed consultant haematologist at Royal Adelaide Hospital who has dedicated most of her life to her work and her special interest has long been amyloidosis.
When Sue was diagnosed with a blood cancer, she found herself living through experiences she had discussed in one of her talks, This is Not the Life I Ordered.